Show simple item record

dc.contributor.authorBradley, Derek
dc.contributor.authorBurke, Mary
dc.contributor.authorRoche, James J.
dc.identifier.citationBradley, D., Burke, M., Roche, J.J. (2016). Characterisation of biopharmaceuticals. Irish Chemical News. 3, 40-72.en_US
dc.identifier.otherArticles - Life and Physical Sciences AITen_US
dc.description.abstractBiopharmaceuticals are drugs which are primarily (glyco)protein in nature, that are produced in living cells using recombinant DNA technology – the combination of genetic material from multiple sources, creating sequences that would not otherwise be found in the genome. They have become an essential component of modern pharmacotherapy, and are the only effective treatment option available for many severe, often lifethreatening, diseases. Biopharmaceutical products have seen unprecedented sales growth in the last decade, particularly when compared with the conventional drug market. Most of the world’s top-selling drugs in 2015 were biopharmaceuticals, accounting for over 70% of the sales revenue for the top ten drug products in that year – see Table 1. The global biopharmaceuticals market currently enjoys a compound annual growth rate of approximately 9%, and is expected to reach an estimated value of over US$250 billion by 2017.en_US
dc.publisherThe Institute of Chemistry of Irelanden_US
dc.relation.ispartofIrish Chemical Newsen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland*
dc.titleCharacterisation of biopharmaceuticalsen_US
dc.rights.accessOpen Accessen_US
dc.subject.departmentFaculty of Science and Healthen_US

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland